Menu

Hamburger Menu Icon
Menu X
Our Solutions
Healthcare Organizations
About
News
Contact Us
Novaseek is transforming how scientists and clinical researchers access real world clinical data and human biospecimens to power life sciences R&D in the era of precision medicine and population health management.

Novaseek’s award-winning novel cloud platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources, and enables researchers to define patient cohorts through population analytics and to obtain biospecimens with longitudinal consented data to advance translational medicine, clinical development and post-launch observational studies.

Our Vision is a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development.

Ready to receive
biospecimens and associated
clinical data?
Complete a Request Form NOW!

Our Solutions

Novaseek Research advances the development of new treatments via its turnkey solutions for observational and real-world data studies, including accessing fully consented biospecimens with associated clinical longitudinal data for research. Its novel Clinical Data Network For Research (CDNR) platform meets the needs of organizations involved in procurement of biospecimens, accrual of patients and use of clinical data to support biomedical research. Our customers include:

  • Bio-Pharma companies involved in drug, device or diagnostic development
  • CROs involved in selecting and recruiting research subject cohorts
  • Researchers conducting observation and real world data studies
  • Entities involved in developing biobanks and patient registries
  • Government and academic research organizations that use biospecimens and clinical data
Novaseek addresses such common challenges as:

  • Insufficient numbers of biospecimens and lack of detailed clinical annotation
  • Difficulty with longitudinal collection of biospecimens and clinical data
  • Lack of access to or transparency of real-world clinical data
  • Inability to prospectively identify patients who meet specific clinical parameters (such as treatment history, diseases, etc.)
  • Inefficient patient consent processes
Novaseek solves these problems in a unique fashion with its CDNR platform that:

  • Uses the electronic medical record (EMR) and other clinical data sources to extract demographic and detailed longitudinal data, such as diagnoses, medications and lab test results
  • Matches EMR data against both research specifications and available laboratory specimens
  • Helps define and track consented patient cohorts and supports the collection of biospecimens at various time points
  • Synthesizes all the donor and biospecimen data for easy reference by end-user researchers
Novaseek works with customers in several ways:

  • As a provider of biospecimens and associated data collected from Novaseek’s own network of hospitals
  • By subscription to the CDNR platform – for companies and research organizations with ongoing needs for biospecimens and/or data. Subscribers use CDNR to plan and recruit cohorts, manage biospecimen requests and track clinical data
  • By licensing CNDR to organizations that want to facilitate biospecimen and associated clinical data acquisitions, and to streamline patient consenting and recruitment for research projects and clinical trials within their own clinical sites
The CDNR platform offers a turn-key, intuitive user experience and ensures clinical relevance and significance of every experiment and every study. Never be limited by not having clinical patient data or the right biospecimens for your projects!
Novaseek App Demo
 
BiospecimensCDNR PlatformCDNR License

Customer Testimonials

default image

We needed to evaluate performance of a novel biomarker in patients with life threatening acute conditions such as heart attack, stroke and organ failure. This was a difficult study that required collection of biospecimens shortly after an acute event and at multiple timepoints during patient recovery. Novaseek had the project set up within a few days, and we got specimens and data that were not available from other vendors. As our partner of choice for studies that require biospecimens and clinical data, Novaseek strengthens our research and our ability to compete for funding. We are now partnering with Novaseek for our future development needs!

President Diagnostic Company

default image

My experience with Novaseek has been extremely positive. I especially loved the speed with which Novaseek was able to arrange the samples. I was afraid it was going to take a few weeks with alternative sources but with Novaseek, we managed to get it done in 2 days. At the end it saved me from delaying my project by a few months, which I am sure researchers can appreciate.

Researcher Academic Lab

For Healthcare Organizations

Novaseek Research enables healthcare organizations and consenting patients to share clinical data and biospecimens for research to generate new revenue, and advance medical research and precision medicine.  Novaseek and healthcare organizations within its network use approved protocols and patient consents to ensure the ethical conduct of research and respect for all participants.

Find Out More




About Novaseek

Novaseek is transforming how researchers access clinical data and human biospecimens. CDNR was developed by experts in drug development, hospital operations, and health IT to create a win-win for industry, academia, healthcare partners and patients.



Leadership


Andrei Soran
Board of Directors, Chairman

Kate Torchilin, PhD, MBA
Board of Directors, Advisor

Bennett Malbon, MBA
Chief Technology Officer

Steve DiPalma
Chief Financial Officer

Derek Tillemans
VP of Business Development, Healthcare Organizations

John Lindsay
VP of Business Development, Pharma and Diagnostics

Dr. Bob Wassman
Medical Director

Career Opportunities



Strategic Partners

mha-logoMassachusetts Hospital Association is a non-profit organization with the mission to advance the health of individuals and communities by serving as the leading voice for all Massachusetts hospitals and healthcare systems and to help them provide high quality, cost-effective and accessible healthcare.


Medexprim LogoMedexprim provides technology and services to enable fast and secured extraction and anonymization of biomedical images and associated data, for any large retrospective or prospective research study requiring secondary image analyses.


hc1-logoThe hc1® Healthcare Relationship Cloud® enables health systems, diagnostic labs and post acute care organizations to grow profitably and deliver amazing service. hc1 has been adopted across more than 1,000 locations across the globe, including Cleveland Clinic, Alere, Nationwide Children’s Hospital and Sonic Healthcare. The company has received accolades from Gartner Research, was named “Best Healthcare CRM for Diagnostic Laboratories” by Frost & Sullivan and is currently the KLAS Healthcare CRM Category Leader with a score of 94.2.

Partner with Us

Novaseek Research was founded by a management team with 100+ combined years of experience in life sciences, Health IT and hospital markets. We understand life sciences R&D. We understand clinical data. We understand hospitals and clinical laboratory operations. Contact us to learn how the Novaseek CDNR platform can become an integral part of your discovery, clinical research, post-launch studies and precision medicine initiatives.

Novaseek Presentation

News

Press Releases/Articles Icon

Press Releases & Articles

Clinical Labs and the Rise of Precision Medicine

Real-world data enables to test hypotheses is advance of clinical trials.

Read More

Novaseek Research Appoints Bennett Malbon as Chief Technology Officer

Company Co-Founder to Lead Technology Strategy and Expansion CAMBRIDGE, MA, June 15, 2017– Novaseek Research Inc., a health IT for life sciences company, today announced that it has named Bennett Malbon as Chief Technology Officer (CTO) for the company. This is an expansion of Bennett’s current role as Vice President, Technology. As CTO, Bennett will […]

Read More

Consented Cohorts Powering Observational Studies

For researchers, well-characterized human samples are valuable commodities. And that’s exactly what Novaseek Research delivers to its customers Novaseek’s CEO Kate Torchilin told Clinical Informatics News last month at a meeting in Boston. “Having the biospecimen is very important here,” she said. “You can only deduce so much from data.”

Read More

Novaseek Research is Named Top 10 Clinical Data Management Solution Provider

CAMBRIDGE, MA, May 25, 2017– Novaseek Research Inc., a health IT for life sciences company, today announced that it was awarded the Top 10 Clinical Data Management Solution Provider 2017 award by Pharma Tech Outlook. The award recognizes 10 companies at the forefront of providing clinical data management solutions for the pharmaceutical industry and impacting […]

Read More

Novaseek Research Announces Partnership with CoxHealth to Advance Biomedical and Clinical Research

Partnership with Missouri Health System Further Expands Access to Biospecimens and Dynamic Real World Data for Research CAMBRIDGE, MA, April 13, 2017 (GLOBE NEWSWIRE) – Novaseek Research Inc, a health IT for life sciences company, today announced it has partnered with CoxHealth, one of the nation’s top 100 integrated health systems, to support and expand […]

Read More
More Press Releases & Articles
RSS Icon

NovaBlog

Timing is Everything: Why Prospective Biospecimen Collection Is Important

Scientists today are increasingly focused on delivering medical innovations tailored to real-world patients. Developing these therapies can be costly, however, and part of the cost can be connected to identifying the right patient sub-population too late in the development process. At Novaseek Research, we aim to drastically reduce the time required to identify the right […]

Read More

The HBS Kraft Precision Medicine Accelerator: A Powerful Voice in Precision Medicine

Last Thursday Novaseek Research had the chance to listen in on the Harvard Business School Kraft Precision Medicine Accelerator Oncology Data Landscape Update call. The Kraft Accelerator was established last year to speed breakthroughs in precision medicine. The Accelerator aims to enable faster commercialization of high-impact innovations by addressing challenges that slow the advancement of […]

Read More

Musings from the Digital Medicine Showcase

Last month I had the opportunity to present Novaseek’s CDNR platform at the second annual Digital Medicine Showcase. This event is a part of the Biotech Showcase event that takes place during the J.P. Morgan Annual Healthcare Conference. Digital Medicine Showcase brings together innovative companies and gives them a forum to present their clinically impactful […]

Read More

Leveraging the Power of Data: The Role of Patient Consent and Efficiency

Last month, Foundation Medicine and Flatiron Health announced an initiative to assemble large genomic databases built around the electronic health records (EHRs), of 20,000 cancer patients. The purpose of this initiative would be to provide a real world data-based tool for oncology reseachers. It’s exciting to think about the possibilities that this type of database […]

Read More

Aligning Drug Development to More Accurately Reflect the Real-World Patient

With the advance of precision medicine, ensuring that clinical studies more accurately reflect real-world patients needs to be at the heart of drug discovery and development. Historically, one of the reasons that so many studies fail is because patient cohorts are often not defined optimally for the treatment being investigated. Step one in changing this […]

Read More
More Blog Posts

Contact Us

Thank you for your interest in Novaseek! To contact our team or request a demo please fill out the form below and we will get back to you as soon as we can. You can also call us at 1-888-632-4311.

Lets Connect

default_rss default_email default_linkedin